This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mégraud, F.
Right arrow Articles by Burman, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mégraud, F.
Right arrow Articles by Burman, C. F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 1999, p. 2747-2752, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Antimicrobial Susceptibility Testing of Helicobacter pylori in a Large Multicenter Trial: the MACH 2 Study

Francis Mégraud,1,* Norbert Lehn,2 Tore Lind,3 Ekkehard Bayerdörffer,4 Colm O'Morain,5 Robin Spiller,6 Peter Unge,7 Sander Veldhuyzen van Zanten,8 Michael Wrangstadh,9 and Carl Fredrik Burman9

Laboratoire de Bactériologie, Hôpital Pellegrin, Bordeaux, France1; Institut für Medizinische Mikrobiologie und Hygiene, University of Regensburg, Regensburg,2 and Medizinische Klinik I, Gastroenterologie, Universitätsklinikum Carl Gustav Carus, Dresden,4 Germany; Department of Surgery, Kärnsjukhuset, Skövde,3 Department of Internal Medicine, Sandviken Hospital, Sandviken,7 and Astra Hässle, Mölndal,9 Sweden; Adelaide & Meath Hospital, Trinity College Dublin, Tallaght, Dublin, Ireland5; Division of Gastroenterology, Queen's Medical Centre, Nottingham, United Kingdom6; and Department of Medicine, Queen Elizabeth II Hospital, Halifax, Nova Scotia, Canada8

Received 4 January 1999/Returned for modification 10 May 1999/Accepted 28 August 1999

Culture and susceptibility testing of Helicobacter pylori strains was performed in a large multinational, multicenter randomized clinical trial. Culture was carried out on gastric biopsy samples obtained from 516 patients at entry and had a sensitivity of 99% when the [13C]urea breath test was used as a reference. Susceptibility testing was performed for clarithromycin and metronidazole on 485 strains by an agar dilution method and the epsilometer test (Etest) and for amoxicillin by an agar dilution method only. Resistance to clarithromycin (>1 µg/ml) was found in 3% of the H. pylori strains, with a perfect correlation between Etest and agar dilution methods. Resistance to metronidazole (>8 µl/ml) was found in 27% of the strains by agar dilution, but there were important discrepancies between it and the Etest method. No resistance to amoxicillin was found. The logarithms of the MICs of the three antibiotics against susceptible strains had a distribution close to normal. The impact of resistance was tested in the four arms of the trial. There were not enough clarithromycin-resistant strains to evaluate the impact of resistance on the cure rate of clarithromycin-based regimens. For metronidazole-resistant strains, the impact noted in the clarithromycin-metronidazole arm was partially overcome when omeprazole was added (76% eradication for resistant strains versus 95% for susceptible strains). Secondary resistance to clarithromycin occurred in strains from 12 of 105 patients (11.4%) after the failure of a clarithromycin-based regimen to effect eradication. The detection of point mutations in clarithromycin-resistant strains was performed by a combination of PCR and restriction fragment length polymorphism. Mutations (A2142G and 2143G) were found in all strains tested except one. This study stresses the importance of performing susceptibility tests in clinical trials in order to explain the results of different treatments.

* Corresponding author. Mailing address: Laboratoire de Bactériologie, Hôpital Pellegrin, 33076 Bordeaux cedex, France. Phone: 33-5 56 79 59 10. Fax: 33-5 56 79 60 18. E-mail: francis.mégraud{at}chu-aquitaine.fr.

Antimicrobial Agents and Chemotherapy, November 1999, p. 2747-2752, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Boyanova, L. (2009). Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria. J Med Microbiol 58: 930-935 [Abstract] [Full Text]  
  • Boyanova, L., Ilieva, J., Gergova, G., Spassova, Z., Nikolov, R., Davidkov, L., Evstatiev, I., Kamburov, V., Katsarov, N., Mitov, I. (2009). Evaluation of clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria. J Med Microbiol 58: 94-100 [Abstract] [Full Text]  
  • Megraud, F. (2007). Helicobacter pylori and antibiotic resistance. Gut 56: 1502-1502 [Full Text]  
  • Megraud, F., Lehours, P. (2007). Helicobacter pylori Detection and Antimicrobial Susceptibility Testing. Clin. Microbiol. Rev. 20: 280-322 [Abstract] [Full Text]  
  • Koletzko, S, Richy, F, Bontems, P, Crone, J, Kalach, N, Monteiro, M L, Gottrand, F, Celinska-Cedro, D, Roma-Giannikou, E, Orderda, G, Kolacek, S, Urruzuno, P, Martinez-Gomez, M J, Casswall, T, Ashorn, M, Bodanszky, H, Megraud, F, on behalf of the European Paediatric Task Force on, (2006). Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 55: 1711-1716 [Abstract] [Full Text]  
  • Salles, N., Menard, A., Georges, A., Salzmann, M., de Ledinghen, V., de Mascarel, A., Emeriau, J.-P., Lamouliatte, H., Megraud, F. (2006). Effects of Helicobacter pylori Infection on Gut Appetite Peptide (Leptin, Ghrelin) Expression in Elderly Inpatients. J Gerontol A Biol Sci Med Sci 61: 1144-1150 [Abstract] [Full Text]  
  • Boyanova, L., Nikolov, R., Lazarova, E., Gergova, G., Katsarov, N., Kamburov, V., Spassova, Z., Derejian, S., Jelev, C., Mitov, I., Krastev, Z. (2006). Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years. J Med Microbiol 55: 65-68 [Abstract] [Full Text]  
  • Lopes, A. I., Quiding-Jarbrink, M., Palha, A., Ruivo, J., Monteiro, L., Oleastro, M., Santos, A., Fernandes, A. (2005). Cytokine Expression in Pediatric Helicobacter pylori Infection. CVI 12: 994-1002 [Abstract] [Full Text]  
  • Kim, J. M., Kim, J. S., Jung, H. C., Kim, N., Kim, Y.-J., Song, I. S. (2004). Distribution of Antibiotic MICs for Helicobacter pylori Strains over a 16-Year Period in Patients from Seoul, South Korea. Antimicrob. Agents Chemother. 48: 4843-4847 [Abstract] [Full Text]  
  • Fujimura, S., Kato, S., Iinuma, K., Watanabe, A. (2004). In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children. J Med Microbiol 53: 1019-1022 [Abstract] [Full Text]  
  • Megraud, F (2004). H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53: 1374-1384 [Full Text]  
  • Boyanova, L., Gergova, G., Koumanova, R., Jelev, C., Lazarova, E., Mitov, I., Kovacheva, Y. (2004). Risk factors for primary Helicobacter pylori resistance in Bulgarian children. J Med Microbiol 53: 911-914 [Abstract] [Full Text]  
  • Taneike, I., Suzuki, K., Nakagawa, S., Yamamoto, T. (2004). Intrafamilial Spread of the Same Clarithromycin-Resistant Helicobacter pylori Infection Confirmed by Molecular Analysis. J. Clin. Microbiol. 42: 3901-3903 [Abstract] [Full Text]  
  • Elviss, N. C., Owen, R. J., Xerry, J., Walker, A. M., Davies, K. (2004). Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother 54: 435-440 [Abstract] [Full Text]  
  • Cameron, E. A.B., Powell, K. U., Baldwin, L., Jones, P., Bell, G. D., Williams, S. G.J. (2004). Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. J Med Microbiol 53: 535-538 [Abstract] [Full Text]  
  • Chisholm, S. A., Owen, R. J. (2004). Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of Helicobacter pylori. J Med Microbiol 53: 135-140 [Abstract] [Full Text]  
  • Boyanova, L., Katsarov, N., Gergova, G., Nikolov, R., Derejian, S., Spassova, Z., Mitov, I., Krastev, Z. (2003). Helicobacter pylori infection in elderly Bulgarian patients. J Med Microbiol 52: 1131-1133 [Full Text]  
  • Lui, S.-Y., Yeoh, K.-G., Ho, B. (2003). Metronidazole-Resistant Helicobacter pylori Is More Prevalent in Patients with Nonulcer Dyspepsia than in Peptic Ulcer Patients in a Multiethnic Asian Population. J. Clin. Microbiol. 41: 5011-5014 [Abstract] [Full Text]  
  • Best, L. M., Haldane, D. J. M., Keelan, M., Taylor, D. E., Thomson, A. B. R., Loo, V., Fallone, C. A., Lyn, P., Smaill, F. M., Hunt, R., Gaudreau, C., Kennedy, J., Alfa, M., Pelletier, R., Veldhuyzen van Zanten, S. J. O. (2003). Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods. Antimicrob. Agents Chemother. 47: 3138-3144 [Abstract] [Full Text]  
  • McMahon, B. J., Hennessy, T. W., Bensler, J. M., Bruden, D. L., Parkinson, A. J., Morris, J. M., Reasonover, A. L., Hurlburt, D. A., Bruce, M. G., Sacco, F., Butler, J. C. (2003). The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections. ANN INTERN MED 139: 463-469 [Abstract] [Full Text]  
  • Oleastro, M., Menard, A., Santos, A., Lamouliatte, H., Monteiro, L., Barthelemy, P., Megraud, F. (2003). Real-Time PCR Assay for Rapid and Accurate Detection of Point Mutations Conferring Resistance to Clarithromycin in Helicobacter pylori. J. Clin. Microbiol. 41: 397-402 [Abstract] [Full Text]  
  • BOYANOVA, L., KOUMANOVA, R., GERGOVA, G., POPOVA, M., MITOV, I., KOVACHEVA, Y., DEREJIAN, S., KATSAROV, N., NIKOLOV, R., KRASTEV, Z. (2002). Prevalence of resistant Helicobacter pylori isolates in Bulgarian children. J Med Microbiol 51: 786-790 [Abstract] [Full Text]  
  • WOLLE, K., LEODOLTER, A., MALFERTHEINER, P., KONIG, W. (2002). Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 51: 705-709 [Abstract] [Full Text]  
  • Gerrits, M. M., Schuijffel, D., van Zwet, A. A., Kuipers, E. J., Vandenbroucke-Grauls, C. M. J. E., Kusters, J. G. (2002). Alterations in Penicillin-Binding Protein 1A Confer Resistance to {beta}-Lactam Antibiotics in Helicobacter pylori. Antimicrob. Agents Chemother. 46: 2229-2233 [Abstract] [Full Text]  
  • (2002). Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study. Gut 50: 779-785 [Abstract] [Full Text]  
  • McNulty, C., and the PHLS Helicobacter Working Group:, , Owen, R., Tompkins, D., Hawtin, P., McColl, K., Price, A., Smith, G., Teare, L. (2002). Helicobacter pylori susceptibility testing by disc diffusion. J Antimicrob Chemother 49: 601-609 [Abstract] [Full Text]  
  • Shuber, A. P., Ascano, J. J., Boynton, K. A., Mitchell, A., Frierson, H. F. Jr., El-Rifai, W.'e., Powell, S. M. (2002). Accurate, Noninvasive Detection of Helicobacter pylori DNA from Stool Samples: Potential Usefulness for Monitoring Treatment. J. Clin. Microbiol. 40: 262-264 [Abstract] [Full Text]  
  • Meyer, J. M., Silliman, N. P., Wang, W., Siepman, N. Y., Sugg, J. E., Morris, D., Zhang, J., Bhattacharyya, H., King, E. C., Hopkins, R. J. (2002). Risk Factors for Helicobacter pylori Resistance in the United States: The Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) Study, 1993-1999. ANN INTERN MED 136: 13-24 [Abstract] [Full Text]  
  • Jeong, J.-Y., Mukhopadhyay, A. K., Akada, J. K., Dailidiene, D., Hoffman, P. S., Berg, D. E. (2001). Roles of FrxA and RdxA Nitroreductases of Helicobacter pylori in Susceptibility and Resistance to Metronidazole. J. Bacteriol. 183: 5155-5162 [Abstract] [Full Text]  
  • van Doorn, L.-J., Glupczynski, Y., Kusters, J. G., Megraud, F., Midolo, P., Maggi-Solca, N., Queiroz, D. M. M., Nouhan, N., Stet, E., Quint, W. G. V. (2001). Accurate Prediction of Macrolide Resistance in Helicobacter pylori by a PCR Line Probe Assay for Detection of Mutations in the 23S rRNA Gene: Multicenter Validation Study. Antimicrob. Agents Chemother. 45: 1500-1504 [Abstract] [Full Text]  
  • Ryan, K. A., van Doorn, L.-J., Moran, A. P., Glennon, M., Smith, T., Maher, M. (2001). Evaluation of Clarithromycin Resistance and cagA and vacA Genotyping of Helicobacter pylori Strains from the West of Ireland Using Line Probe Assays. J. Clin. Microbiol. 39: 1978-1980 [Abstract] [Full Text]  
  • Kim, J. J., Reddy, R., Lee, M., Kim, J. G., El-Zaatari, F. A. K., Osato, M. S., Graham, D. Y., Kwon, D. H. (2001). Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 47: 459-461 [Abstract] [Full Text]  
  • Broutet, N., Marais, A., Lamouliatte, H., de Mascarel, A., Samoyeau, R., Salamon, R., Megraud, F. (2001). cagA Status and Eradication Treatment Outcome of Anti-Helicobacter pylori Triple Therapies in Patients with Nonulcer Dyspepsia. J. Clin. Microbiol. 39: 1319-1322 [Abstract] [Full Text]  
  • Kwon, D. H., Kim, J. J., Lee, M., Yamaoka, Y., Kato, M., Osato, M. S., El-Zaatari, F. A. K., Graham, D. Y. (2000). Isolation and Characterization of Tetracycline-Resistant Clinical Isolates of Helicobacter pylori. Antimicrob. Agents Chemother. 44: 3203-3205 [Abstract] [Full Text]  
  • Jeong, J.-Y., Mukhopadhyay, A. K., Dailidiene, D., Wang, Y., Velapatino, B., Gilman, R. H., Parkinson, A. J., Nair, G. B., Wong, B. C. Y., Lam, S. K., Mistry, R., Segal, I., Yuan, Y., Gao, H., Alarcon, T., Brea, M. L., Ito, Y., Kersulyte, D., Lee, H.-K., Gong, Y., Goodwin, A., Hoffman, P. S., Berg, D. E. (2000). Sequential Inactivation of rdxA (HP0954) and frxA (HP0642) Nitroreductase Genes Causes Moderate and High-Level Metronidazole Resistance in Helicobacter pylori. J. Bacteriol. 182: 5082-5090 [Abstract] [Full Text]  
  • Solca, N. M., Bernasconi, M. V., Piffaretti, J.-C. (2000). Mechanism of Metronidazole Resistance in Helicobacter pylori: Comparison of the rdxA Gene Sequences in 30 Strains. Antimicrob. Agents Chemother. 44: 2207-2210 [Abstract] [Full Text]  
  • Kato, M., Yamaoka, Y., Kim, J. J., Reddy, R., Asaka, M., Kashima, K., Osato, M. S., El-Zaatari, F. A. K., Graham, D. Y., Kwon, D. H. (2000). Regional Differences in Metronidazole Resistance and Increasing Clarithromycin Resistance among Helicobacter pylori Isolates from Japan. Antimicrob. Agents Chemother. 44: 2214-2216 [Abstract] [Full Text]  
  • Hirschl, A. M., Apfalter, P., Makristathis, A., Rotter, M. L., Wimmer, M. (2000). In Vitro Activities of Linezolid Alone and in Combination with Amoxicillin, Clarithromycin, and Metronidazole against Helicobacter pylori. Antimicrob. Agents Chemother. 44: 1977-1979 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»